Trial Profile
Pivotal Phase 3 trial of Glycerol phenylbutyrate in patients with hepatic encephalopathy
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Mar 2015
Price :
$35
*
At a glance
- Drugs Glycerol phenylbutyrate (Primary)
- Indications Hepatic encephalopathy
- Focus Therapeutic Use
- Sponsors Hyperion Therapeutics
- 12 Mar 2015 New trial record
- 27 Feb 2015 According to a Hyperion Therapeutics media release, this trial is expected to begin in second half of 2015.